Ads
related to: lungs duncan macmillan
Search results
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 58 minutes agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
Incurable lung cancer could be ‘stopped in tracks’ by new pill
The Telegraph via Yahoo News· 2 hours agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Strong trial results for Pfizer lung cancer drug | FOX 28 Spokane
FOX 28 Spokane· 2 hours agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 2 hours agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Lung Scarring: What to Know
Verywell Health via Yahoo News· 22 hours agoLung scarring, called pulmonary fibrosis, is a serious, permanent condition, but treatments are available. Medically reviewed by Sanja Jelic, MDMedically...
This Facial Change Could Be a Sign of Lung Cancer, According to Pulmonologists
Parade via Yahoo News· 4 days agoWoman looking at facial changes in the mirror The World Health Organization counts lung cancer among...
Gilead's Trodelvy extends lung cancer survival by just 1.3 months in trial
Reuters via AOL· 2 hours agoGilead Sciences' Trodelvy improved survival by 1.3 months more than chemotherapy in previously...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 2 hours agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 2 hours agoResults from a trial of daily pill lorlatinib were described as "unprecedented".